Applications of Molecular Diagnostics in Discovery and Development of Novel Therapeutics to be Addressed by Industry Leaders at Princeton, NJ Conference

Sep 22, 2004, 01:00 ET from Strategic Research Institute

    NEW YORK, Sept. 22 /PRNewswire/ -- The world's largest pharmaceutical and
 diagnostics manufacturers will present on their most recent data in the
 application of molecular diagnostics in the discovery and development of new
 drugs at a comprehensive, industry-wide conference to be held in Princeton,
 NJ, announces Strategic Research Institute.
     New technologies and applications in biomarker discovery and translation,
 gene expression profiling, pharmacogenomics, systems biology, in vivo imaging,
 and nanotechnology will be presented via keynote and plenary presentations,
 followed by a panel discussion on the use of molecular imaging agents for
 disease detection in MRI.
     Leading clinicians and scientists from Pfizer, Lilly Research Labs,
 Kereos, Quest Diagnostics, Hoffman La Roche, the National Cancer Institute,
 and many others will be among the 20+ presenting faculty at the two-day
 meeting to be held in February, 2005.
     To request announcement, or for speaking opportunities, please contact
 Steve J. Kuperberg at
     For sponsorship & exhibition opportunities, please contact Don Buford at

SOURCE Strategic Research Institute